PT979098E - Metodo para o tratamento da hiperprolactinemia e de prolactinomas - Google Patents

Metodo para o tratamento da hiperprolactinemia e de prolactinomas

Info

Publication number
PT979098E
PT979098E PT98918696T PT98918696T PT979098E PT 979098 E PT979098 E PT 979098E PT 98918696 T PT98918696 T PT 98918696T PT 98918696 T PT98918696 T PT 98918696T PT 979098 E PT979098 E PT 979098E
Authority
PT
Portugal
Prior art keywords
hyperprolactinemia
prolactinomas
treatment
administers
animal
Prior art date
Application number
PT98918696T
Other languages
English (en)
Inventor
Shlomo Melmed
Ilan Shimon
Michael D Culler
Original Assignee
Cedars Sinai Medical Center
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/852,221 external-priority patent/US5972893A/en
Application filed by Cedars Sinai Medical Center, Sod Conseils Rech Applic filed Critical Cedars Sinai Medical Center
Publication of PT979098E publication Critical patent/PT979098E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
PT98918696T 1997-05-01 1998-04-24 Metodo para o tratamento da hiperprolactinemia e de prolactinomas PT979098E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4524197P 1997-05-01 1997-05-01
US08/852,221 US5972893A (en) 1997-05-06 1997-05-06 Method of treating hyperprolactinemia and prolactinomas

Publications (1)

Publication Number Publication Date
PT979098E true PT979098E (pt) 2003-07-31

Family

ID=26722530

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98918696T PT979098E (pt) 1997-05-01 1998-04-24 Metodo para o tratamento da hiperprolactinemia e de prolactinomas

Country Status (8)

Country Link
EP (1) EP0979098B1 (pt)
JP (1) JP2001523265A (pt)
AT (1) ATE234113T1 (pt)
DE (1) DE69812084T2 (pt)
DK (1) DK0979098T3 (pt)
ES (1) ES2195333T3 (pt)
PT (1) PT979098E (pt)
WO (1) WO1998050063A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0201696A3 (en) * 1999-06-25 2002-10-28 Sod Conseils Rech Applic Cyclic peptides, pharmaceutical compositions comprising thereof and their use
US6864234B1 (en) 1999-06-25 2005-03-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Somatostatin agonists
CA2388807C (en) 1999-11-12 2013-08-06 Matthew C. Coffey Viruses for the treatment of cellular proliferative disorders
CA2743731C (en) 2001-03-06 2014-05-06 The Administrators Of The Tulane Educational Fund Method of modulating the proliferation of medullary thyroid carcinoma cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US5708135A (en) * 1995-09-29 1998-01-13 Biomeasure Incorporated Cyclic peptide analogs of somatostatin

Also Published As

Publication number Publication date
EP0979098A1 (en) 2000-02-16
WO1998050063A1 (en) 1998-11-12
JP2001523265A (ja) 2001-11-20
ATE234113T1 (de) 2003-03-15
DE69812084T2 (de) 2003-12-24
EP0979098B1 (en) 2003-03-12
DK0979098T3 (da) 2003-07-14
DE69812084D1 (de) 2003-04-17
ES2195333T3 (es) 2003-12-01

Similar Documents

Publication Publication Date Title
BR9407424A (pt) Métodos para regular motilidade gastrointestinal
WO2000012111A3 (en) Selective treatment of endothelial somatostatin receptors
HK1059404A1 (en) Use of specific erbb4 antagonists for treating stenosis
HUP9700368A2 (hu) II-típusú diabetes mellitus kezelése amilin agonistákkal
IT1208521B (it) Elettrodo, apparecchiatura e defibrillazione per l'impianto in corpi umani o animali.
GB9818916D0 (en) Use
DE69721458T2 (de) Ausrüstung enthaltend eine implantierbare Vorrichtung
DE60016387D1 (de) Intravesikaler ballon
WO2002041837A3 (en) Treatment of mucositis
NZ513472A (en) Apparatus for treating fractured or diseased bone using plastically expandable bodies
HK1051005A1 (en) Methods and compositions for modulating alpha adrenergic receptor activity
AU1565300A (en) Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol
AU7814498A (en) Multivalent (in ovo) avian vaccine
IL138060A0 (en) C-myc coding region determinant-binding protein (crd-bp)
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
PL338126A1 (en) Treatment of diabetes by means of derivatives of thiazolydinone, of insulin secretion stimulating agent and of biguanidinic derivative
PT979098E (pt) Metodo para o tratamento da hiperprolactinemia e de prolactinomas
DK1726651T3 (da) Fremgangsmåde til behandling af muskulære lidelser
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
DK1225906T3 (da) Mekanisk forlængede nerveceller og fremgangsmåde til at producere og anvende disse celler
ATE490780T1 (de) Menschliches wachstumshormon zur behandlung von anorexia nervosa
IT8421585V0 (it) Perno sagomato per impianto ednosseo, utilizzabile nelle protesi dentarie.
UA49495A (uk) Спосіб лікування переломів кісток
IT8422298V0 (it) Struttura di perno sagomato, per impianto endosseo, utilizzabile nelle protesi dentarie.
UA32167A (uk) Спосіб прогнозування появи негативної реакції крові при плануванні магнітотерапії, лазеротерапії, увч-терапії у хворих з травматичним переломом та остеомієлітом нижньої щелепи